**COMING SOON**
With MarginProbe, surgeons can assess the tissue in the operating room to give them greater confidence that they successfully removed all the cancer in the first lumpectomy surgery and will not require the patient to come back for another surgery.
The technology uses radio-frequency (RF) electrical fields to probe the tissue in order to identify any cancer that may be remaining on the surface of the tissue removed from the breast. If MarginProbe identifies cancer on the surface of the tissue the surgeon will remove additional tissue from the breast at the time of surgery, without the need to wait for the pathology.
For more information feel free to give us a call or drop us an email.